CoChat

Serum Procollagen Peptides and Collagen Type Vi for the Assessment of Activity and Degree of Hepatic Fibrosis in Schistosomiasis and Alcoholic Liver Disease

Open access
Shahin, Manal, Schuppan, Detlef, Waldherr, Rüdiger, Risteli, Juha, Risteli, Leila, Savolainen, Eeva-Riitta, Oesterling, Christine, Abdel Rahman, Hosna M., El Sahly, Abdul M., Abdel Razek, Samia M., Ruby, Omar El, Koch, Armin, Seitz, Helmut K. · 1992 · Hepatology
Cited by 86

The DOI matches its Crossref record.

Abstract

Schistosomiasis, in contrast to alcoholic liver disease, leads to presinusoidal hepatic fibrosis, which determines the prognosis of the disease. Because conventional liver function tests and liver biopsy specimens provide little information about the dynamics of the fibrotic process, we measured the serum concentrations of procollagen type III N–propeptide and procollagen type I C–propeptide, believed to mainly reflect collagen synthesis, and procollagen type IV C–propeptide and collagen type VI, two presumptive markers of collagen degradation. Determinations were performed in 15 healthy control subjects, 69 patients with various stages of infection with Schistosoma mansoni/Schistosoma haematobium (28) with an early active infection and no organ involvement, 27 with hepatosplenic involvement and 14 with complications of portal hypertension) and 16 patients with alcoholic cirrhosis. In addition, liver biopsy specimens were obtained from 30 schistosomal patients (18 with hepatosplenic involvement and 12 with complications of portal hypertension for histopathological grading and collagen histochemistry. Procollagen type III N–propeptide was significantly elevated in the three patient groups with schistosomiasis when compared with controls (p < 0.01). Also, patients with higher histological grading showed significantly higher procollagen type III N–propeptide values (p < 0.05). In alcoholic patients, procollagen type III N–propeptide was even higher and increased parallel to the severity of the disease, determined by using a combined clinical and laboratory index. Procollagen type I C–propeptide was only elevated in early infection (p < 0.05) and steadily decreased with disease progression. In contrast, procollagen type IV C–propeptide and collagen type VI were not significantly elevated in those patients with no organ involvement but increased significantly in those patients with hepatosplenic involvement (p < 0.01) and those patients with complications of portal hypertension (p < 0.01 and p < 0.02, respectively). Immunohistological findings for the above mentioned collagen types did not correlate with their corresponding serum levels. The data show that a serum elevation of procollagen type III N–propeptide may indicate early fibrogenic activity in patients with schistosomal infection; in addition, the combined measurement of procollagen type III N–propeptide with procollagen type IV C–propeptide and collagen type VI seems to provide additional information to predict progressive hepatic fibrosis. (Hepatology 1992;15:637-644).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.1840150414

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

Metadata

Authors
Shahin, M., Schuppan, D., Waldherr, R., Risteli, J., Risteli, L., Savolainen, E.-R., Oesterling, C., Abdel Rahman, H. M., El Sahly, A. M., Abdel Razek, S. M., Ruby, O. E., Koch, A., & Seitz, H. K.
Venue
Hepatology
Published
1992-04
Volume
15
Issue
4
Pages
637-644
ISSN
0270-9139 (ISSN-L)
OpenAlex
W2112131056
Cited by
86
References
0
FWCI
2.12
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.